alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 24,976–25,000 of 27,380 studies, newest first · page 1000 of 1096.

January 2002 16

  1. 2002-01-01

    Patterns of brain atrophy in frontotemporal dementia and semantic dementia

    ✓ Peer-reviewed Lewy body dementia Neurology

    Key finding: Although FTD and SemD are associated with different overall patterns of brain atrophy, regions of gray matter tissue loss in the orbital frontal, insular, and anterior cingulate regions are present in both groups. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2002-01-01

    Patterns of cerebral atrophy in primary progressive aphasia

    ✓ Peer-reviewed Digital health tools The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: The syndrome may be associated with frontotemporal dementia (FTD)- or Alzheimer disease (AD)-type changes. +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2002-01-01

    Neuropsychiatric features of frontotemporal dementia: evaluation of consensus criteria and review

    ✓ Peer-reviewed Digital health tools The Journal of neuropsychiatry and clinical neurosciences

    Key finding: The authors evaluated the neuropsychiatric features of 53 FTD patients and retrospectively applied the Consensus Criteria for this disorder. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2002-01-01

    Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease: a case series

    ✓ Peer-reviewed Digital health tools Current medical research and opinion

    Key finding: Here, we present a case series of patients with Parkinson's disease and dementia who we treated with rivastigmine, a dual inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) that shows brain region-selectivity. +4 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2002-01-01

    Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease

    ✓ Peer-reviewed Treatments CNS drug reviews

    Key finding: It is extensively metabolized in numerous pathways, mainly in the liver via cytochrome P450 enzymes CYP2D6 and CYP3A4, and has a low potential for clinically significant drug-drug interactions. +4 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2002-01-01

    Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study

    ✓ Peer-reviewed Brain scans and imaging Dementia and geriatric cognitive disorders

    Key finding: However, pathology showed significantly more extensive changes than did MRI in all cases, with a mean of 54% larger areas.

    Full summary, score breakdown and related studies → Original source

  7. 2002-01-01

    [Reliability and validity of the standardized Mini Mental State Examination in the diagnosis of mild dementia in Turkish population]

    ✓ Peer-reviewed Getting a diagnosis Turk psikiyatri dergisi = Turkish journal of psychiatry

    Key finding: The results of this study showed that the Turkish version of the SMMSE has high reliability and validity for the diagnosis of mild dementia in Turkish population. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2002-01-01

    Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group

    ✓ Peer-reviewed Getting a diagnosis JAMA

    Key finding: Excessive daytime sleepiness was present overall in 327 (51%) of the 638 patients and in 213 (51%) of the 420 drivers. +1 more finding

    Full summary, score breakdown and related studies → Original source

  9. 2002-01-01

    Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study

    ✓ Peer-reviewed Prevention and risk Journal of the American Geriatrics Society

    Key finding: Incidence of dementia in Italy paralleled that in most industrialized countries. +3 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2002-01-01

    The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava

    ✓ Peer-reviewed Prevention and risk Annals of internal medicine

    Key finding: The published evidence suggests that ginkgo is of questionable use for memory loss and tinnitus but has some effect on dementia and intermittent claudication.

    Full summary, score breakdown and related studies → Original source

  11. 2002-01-01

    H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine

    ✓ Peer-reviewed Treatments Alzheimer disease and associated disorders

    Key finding: These results do not support claims for the efficacy of nizatidine in over-the-counter dosages as a means of preventing symptom progression in AD. +1 more finding

    Full summary, score breakdown and related studies → Original source

  12. 2002-01-01

    HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier

    ✓ Peer-reviewed Treatments The journal of nutrition, health & aging

    Key finding: Increased circulating cholesterol has been long linked to an increased risk of coronary artery disease (CAD), and is now linked to an increased risk of developing Alzheimer s disease (AD). +2 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2002-01-01

    Snoezelen for dementia

    ✓ Peer-reviewed Treatments The Cochrane database of systematic reviews

    Key finding: Practitioners are keen to use snoezelen in dementia care, and some encouraging results have been documented in the area of promoting adaptive behaviours (e.g. +4 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2002-01-01

    Specificity of brain activation patterns in people at genetic risk for Alzheimer disease

    ✓ Peer-reviewed Genetics The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry

    Key finding: However, the two genetic groups showed no differences in activation patterns even at the most difficult task level, suggesting that additional cognitive effort in persons at genetic risk for AD is specific to episodic encoding and is not merely a reflection of task difficulty.

    Full summary, score breakdown and related studies → Original source

  15. 2002-01-01

    Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet

    ✓ Peer-reviewed Genetics The journal of nutrition, health & aging

    Key finding: Although plasma cholesterol levels are not generally associated with Alzheimer disease (AD) incidence, in vitro studies have found that increased cellular cholesterol levels are associated with increases in -amyloid (A ) production, with a concomitant decrease in sAPPa, the secreted non amyloidogenic fragment of the amyloid precursor protein (APP). +4 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2002-01-01

    Risk of dementia among white and African American relatives of patients with Alzheimer disease

    ✓ Peer-reviewed Genetics JAMA

    Key finding: However, in this study, the additional risk of dementia conferred by being a first-degree relative, by being female, or by the probability of having an APOE epsilon4 allele appeared similar in African American and white families.

    Full summary, score breakdown and related studies → Original source

December 2001 9

  1. 2001-12-20

    The synucleins

    ✓ Peer-reviewed Brain scans and imaging Genome biology

    Key finding: Mutations in alpha-synuclein are associated with rare familial cases of early-onset Parkinson's disease, and the protein accumulates abnormally in Parkinson's disease, Alzheimer's disease, and several other neurodegenerative illnesses.

    Full summary, score breakdown and related studies → Original source

  2. 2001-12-13

    A sensitive and quantitative assay for measuring cleavage of presenilin substrates

    ✓ Peer-reviewed Risk genes beyond APOE The Journal of biological chemistry

    Key finding: Here we present a novel cell-based reporter gene assay for the quantification of PS-controlled gamma-secretase cleavage of the Alzheimer amyloid precursor protein (APP). +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2001-12-01

    Neurosteroid metabolism in the human brain

    ✓ Peer-reviewed Risk factors European Journal of Endocrinology

    Key finding: This review summarizes the current knowledge of the biosynthesis of neurosteroids in the human brain, the enzymes mediating these reactions, their localization and the putative effects of neurosteroids. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2001-12-01

    Prevalence of depression and depression recognition in nursing homes

    ✓ Peer-reviewed Health systems and care delivery Social psychiatry and psychiatric epidemiology

    Key finding: The prevalence of depressive disorders among nursing home residents is high; depression recognition is relatively low, with only 37%-45% of cases diagnosed by psychiatrists recognized as depressed by staff. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2001-12-01

    Apathy in Alzheimer's disease

    ✓ Peer-reviewed Caregiving Journal of the American Geriatrics Society

    Key finding: Patients with apathy suffer from decreased daily function and specific cognitive deficits and rely on families to provide more care, which results in increased stress for families. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2001-12-01

    Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

    ✓ Peer-reviewed Disease mechanisms Trends in molecular medicine

    Key finding: Recent research suggests that these observations might be linked, and it is postulated that Abeta-induced oxidative stress leads to neurodegeneration in AD brain.

    Full summary, score breakdown and related studies → Original source

  7. 2001-12-01

    Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms

    ✓ Peer-reviewed Disease mechanisms Journal of applied physiology (Bethesda, Md. : 1985)

    Key finding: However, we also find nonnuclear estrogen receptors outside of the cell nuclei in dendrites, presynaptic terminals, and glial cells, where estrogen receptors may couple to second messenger systems to regulate a variety of cellular events and signal to the nuclear via transcriptional regulators such as CREB. +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2001-12-01

    Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier

    ✓ Peer-reviewed Vascular contributions Trends in neurosciences

    Key finding: Disruption of the tight junctions (TJs) of the blood-brain barrier (BBB) is a hallmark of many CNS pathologies, including stroke, HIV encephalitis, Alzheimer's disease, multiple sclerosis and bacterial meningitis. +3 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2001-12-01

    Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women

    ✓ Peer-reviewed Hippocampus size on brain scans Neurology

    Key finding: The presence of a single APOE-epsilon4 allele is associated with an increased rate of hippocampal volume loss in healthy women in their sixth decade of life that is not related to any detectable memory changes. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →